Author: Maldonado-Cabrera, AnahÃ; Angulo-Molina, Aracely; Haque, Ubydul; Velazquez, Carlos; Ãlvarez-Villaseñor, Andrea S.; Santacruz-Gómez, Karla J.; Gallego-Hernández, Ana L.
Title: Acute Inflammatory Mediators in Young Adult Patients with COVID-19 in Mexico Cord-id: b5lsm1pw Document date: 2021_8_20
ID: b5lsm1pw
Snippet: Young adults (18–40 years old) are an active population with high risk of infection and transmission of COVID-19. They are considered a low-risk population due to its low 1.0% case fatality rate (CFR). Despite their high clinical usefulness to prevent fatal cases, inflammatory and coagulation biomarkers studies are limited. For this reason, we performed a retrospective cohort study with COVID-19 patients in Hermosillo, Mexico, to assess inflammation, coagulopathy profile, and severity outcomes
Document: Young adults (18–40 years old) are an active population with high risk of infection and transmission of COVID-19. They are considered a low-risk population due to its low 1.0% case fatality rate (CFR). Despite their high clinical usefulness to prevent fatal cases, inflammatory and coagulation biomarkers studies are limited. For this reason, we performed a retrospective cohort study with COVID-19 patients in Hermosillo, Mexico, to assess inflammation, coagulopathy profile, and severity outcomes in young adults. We analyzed blood samples to determine the neutrophil/lymphocyte ratio (NLR), neutrophil/monocyte ratio (NMR), lymphocyte/monocyte ratio (LMR), platelet/lymphocyte ratio (PLR), and C-reactive protein (C-RP). We included epidemiological features and comorbidities, and compared them to the severity status. Only 359 COVID-19-confirmed young adults were included in the ambulatory (44.8%), hospitalized (42.9%), and death (12%) severity groups. Laboratory results showed an increase in NMR, LMR, and C-RP associated with the aggravated patients. Additionally, obesity, arterial hypertension, and type-2 diabetes mellitus (T2DM) were associated with the COVID-19 severity outcome. We found that 9.1% and 30.3% of young adults presented the novel COVID-19-associated coagulopathy (CAC) and the risk of CAC, respectively. These parameters can be considered independent biomarkers reflecting an enhanced inflammatory process related to the COVID-19 prognosis.
Search related documents:
Co phrase search for related documents- activation inflammation and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- activation inflammation and acute inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- activation inflammation and acute phase: 1, 2, 3, 4, 5, 6, 7
- activation inflammation and acute phase response: 1
- acute ards respiratory distress syndrome and additionally obesity: 1, 2
- acute ards respiratory distress syndrome and low prevalence: 1, 2
- acute ards respiratory distress syndrome and lung bacterial infection: 1, 2, 3
- acute inflammatory and low prevalence: 1
- acute inflammatory and lung bacterial infection: 1
- acute phase and lmr lymphocyte monocyte ratio: 1
- acute phase and low prevalence: 1, 2, 3, 4, 5, 6, 7
- acute phase and lung bacterial infection: 1
- acute phase response and lung bacterial infection: 1
Co phrase search for related documents, hyperlinks ordered by date